Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Medulloblastoma × Triiodothyronine × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 3 Hypothyroidism 2 Prostatic Neoplasms 1 Neoplasms 1 Medulloblastoma 1 Goiter 1 Gliosarcoma 1 Glioblastoma 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 18 Temozolomide 15 Etoposide 15 Carboplatin 14 Filgrastim 13 Radiotherapy 10 Vincristine 9 Cisplatin 9 Thiotepa 8 Melphalan 8 Granulocyte Colony-Stimulating Factor 7 etoposide phosphate 6 Lomustine 6 Peripheral Blood Stem Cell Transplantation 5 Methotrexate 5 Magnetic Resonance Spectroscopy 5 Topotecan 4 Radiation 4 Busulfan 4 sargramostim 3 Thalidomide 3 Stem Cell Transplantation 3 Mesna 3 Irinotecan 3 Ifosfamide 3 Gemcitabine 3 Donepezil 3 Automobiles 3 sodium thiosulfate 2 pegfilgrastim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07346157 2026-01-16

PNOC044

University of California, San Francisco

Phase 1/2 Not yet recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡